Alzex Neuropharma Inc. (TRRI)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Feb 6, 2026
Alzex Neuropharma Revenue
In the year 2011, Alzex Neuropharma had annual revenue of $4.73M with 23.83% growth. Alzex Neuropharma had revenue of $916.10K in the quarter ending June 30, 2011, with 23.58% growth.
Revenue
4.73M
Revenue Growth
+6.73%
P/S Ratio
0.00
Revenue / Employee
430.37K
Employees
11
Market Cap
452.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2011 | 4.73M | 911.14K | 23.83% |
| Dec 31, 2010 | 3.82M | -4.98M | -56.58% |
| Dec 31, 2009 | 8.80M | -6.18M | -41.24% |
| Dec 31, 2008 | 14.98M | -142.18K | -0.94% |
| Dec 31, 2007 | 15.13M | 868.37K | 6.09% |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAlzex Neuropharma News
- 3 years ago - Trinity Resources Inc. Awaiting Regulatory Approval of Name and Symbol Change - Newsfile Corp
- 3 years ago - Trinity Resources Inc. Finalizes the Purchase of Alzex Biomedical Assets and Intellectual Property - Newsfile Corp